Mass ivermectin treatment for onchocerciasis: Lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity

Filaria Journal

Volumn 4, Issue , 2005, Pages

  Richards Jr , F O ^a   Eigege, A ^a   Pam, D ^b   Kal, A ^a   Lenhart, A ^a   Oneyka, J O A ^b   Jinadu, M Y ^c   Miri, E S ^a  

^a CARTER CENTER   (United States)

^b UNIVERSITY OF JOS   (Nigeria)

^c Federal Ministry of Health   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN;

ANOPHELES; ARTICLE; CHI SQUARE TEST; COMMUNITY CARE; CONTROLLED STUDY; DISSECTION; EVIDENCE BASED MEDICINE; FILARIASIS; HEAD; HEALTH PROGRAM; HUMAN; LARVAL STAGE; MANTEL HAENSZEL TEST; MOSQUITO; NIGERIA; NONHUMAN; ONCHOCERCIASIS; PARASITE TRANSMISSION; PARASITE VECTOR; SPECIES ENDEMICITY; THORAX; WUCHERERIA BANCROFTI; ZOOLOGY;

EID: 26844563309     PISSN: 14752883     EISSN: 14752883     Source Type: Journal    
DOI: 10.1186/1475-2883-4-6     Document Type: Article

References (11)

1. Richards FO, Boatin B, Sauerbrey M, Sékétéli A: Control of Onchocerciasis Today: Status and Challenges. Trends Parasitol 2001, 17:558-563.
2. Brown KR, Ricci FM, Ottesen EA: Ivermectin: effectiveness in lymphatic filariasis. Parasitology 2000, 121(Suppl):S133-146.
3. Molyneux DH, Zagaria N: Lymphatic filariasis elimination: progress in global programme development. Annals Trop Med Parasitol 2002, 96(Supp 2):S15-40.
4. Addiss DG, Beach MJ, Streit TG, Lutwick S, LeConte FH, Lafontant JG, Hightower AW, Lammie PJ: Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children. Lancet 1997, 350:480-484.
5. Ottesen EA, Ismail MM, Horton J: The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999, 15(9):382-386.
6. Dunyo SK, Nkrumah FK, Simonsen PE: Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment. Trans R Soc Trop Med Hyg 2000, 94(4):437-443.
7. Kyelem D, Sanou S, Boatin B, Medlock J, Coulibaly S, Molyneux DH: Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications. Ann Trop Med Parasitol 2003, 97(8):827-838.
8. Hopkins DR, Eigege A, Miri ES, Gontor I, Ogah G, Umaru J, Gwomkudu CC, Mathai W, Jinadu MY, Amadiegwu S, Oyenekan OK, Korve K, Richards FO: Lymphatic filariasis elimination and schistosomiasis control in combination with onchocerciasis control in Nigeria. Am J Trop Med Hyg 2002, 67(3):266-272.
9. Richards FO Jr, Pam DD, Kal A, Gerlong GY, Onyeka J, Sambo Y, Danboyi J, Ibrahim B, Terranella A, Kumbak D, Dakul A, Lenhart A, Rakers L, Umaru J, Amadiegwu S, Withers PC Jr, Mafuyai H, Jinadu MY, Miri ES, Eigege A: Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectinbased, mass treatments in Nigeria. Ann Trop Med Parasitol 2005, 99(2):155-64.
10. Weil GJ, Lammie PJ, Weiss N: The ICT Filariasis Test: A rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitology Today 1997, 13:401-404.
11. Eigege A, Richards F, Blaney D, Miri E, Umaru J, Jinadu M, Mathai W, Hopkins D: Rapid assessment for lymphatic filariasis in central Nigeria: a comparison of the immunochromatographic card test and hydrocele rates in an area of high endemicity. Am J Trop Med Hyg 2003, 68:643-646.